Influx Healthtech

INFLUX

Q: Is the debt of Influx Healthtech increasing or decreasing?

Yes, The net debt of Influx Healthtech is increasing.Latest net debt of Influx Healthtech is -₹2.88 Crs as of Sep-25.This is greater than Mar-25 when it was -₹3.59 Crs.

Q: Has the share price of Influx Healthtech grown faster than its competition?

There is not enough historical data for the companies share price.

Price

Micro Cap

₹498 Cr.

New to Zerodha? Sign-up for free.

Influx Healthtech is a reliable Contract Development and Manufacturing Organization (CDMO) specializing in healthcare-focused contract manufacturing. They offer specialized services to clients in mul… More

Influx Healthtech is a reliable Contract Development and Manufacturing Organization (CDMO) speciali… More

Low

120

52W Range

High

261

37.24

Sector PE

26.27

P/B

13.78

Div.Yield

ROE

36.98%

EBIDTA

20.89

ROCE

49.41

EPS

New to Zerodha? Sign-up for free.

Get instant stock alerts

Share Price
Financials
Revenue mix
Shareholdings
Peers
Forensics

Coming soon

Summary
Profit & Loss
Balance sheet
Cashflow

Yearly | Quarterly

View Detailed Summary

This data is currently unavailable for this company.

Yearly | Quarterly

(In Cr.)

(In Cr.)
This data is currently unavailable for this company.

Financial Ratio's

(In %)

Detailed P&L Report

(In Cr.)

Detailed Balance Sheet

Financial Year (In Cr.)

Detailed Cash Flow

Product wise
Location wise

INFLUX
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

INFLUX
Revenue Mix

Latest

Historic

This data is currently unavailable for this company.

More Info

Shareholdings

Holders

Detailed Shareholdings

This data is currently unavailable for this company.

Peers

Detailed Peers

Forensics

View Detailed Forensics

Recent events

News
Corporate Actions

Influx Healthtech Says Completion Of Good Manufacturing Practices Inspection From Tanzania Bureau Of Standards At Facility

Mar 05, 2026

Events:

Quarterly Results

Announcement Date

Nov 12, 2025

More Micro Cap Ideas

See similar 'Micro' cap companies with recent activity

Promoter Buying

Companies where the promoters are bullish

Detailed List

Capex

Companies investing on expansion

Detailed List

Superstar Investor

Companies where well known investors have invested

Detailed List

Popular questions

Business
Financials
Share Price
Shareholdings

What does Influx Healthtech do?

Influx Healthtech is a healthcare-focused company specialising in contract manufacturing. The company is a reliable Contract Development and Manufacturing Organization (CDMO), providing specialized services to clients in multiple industries. The company has diversified product portfolio.

Who are the competitors of Influx Healthtech?

Influx Healthtech major competitors are Sudarshan Pharma Ind, Quest Laboratories. Market Cap of Influx Healthtech is ₹496 Crs. While the median market cap of its peers are ₹381 Crs.

Is Influx Healthtech financially stable compared to its competitors?

Influx Healthtech seems to be financially stable compared to its competitors. The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Does Influx Healthtech pay decent dividends?

The company seems to be paying a very low dividend. Investors need to see where the company is allocating its profits. Influx Healthtech latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

How has Influx Healthtech allocated its funds?

Companies resources are allocated to majorly unproductive assets like Accounts Receivable

How strong is Influx Healthtech balance sheet?

Influx Healthtech balance sheet is weak and might have solvency issues

Is the profitablity of Influx Healthtech improving?

Yes, profit is increasing. The profit of Influx Healthtech is ₹15.64 Crs for TTM, ₹13.37 Crs for Mar 2025 and ₹11.13 Crs for Mar 2024.

Is the debt of Influx Healthtech increasing or decreasing?

Yes, The net debt of Influx Healthtech is increasing. Latest net debt of Influx Healthtech is -₹2.88 Crs as of Sep-25. This is greater than Mar-25 when it was -₹3.59 Crs.

Is Influx Healthtech stock expensive?

Influx Healthtech is expensive when considering the PE ratio, however latest EV/EBIDTA is < 3 yr avg EV/EBIDTA. Latest PE of Influx Healthtech is 37.13, while 3 year average PE is 32.97. Also latest EV/EBITDA of Influx Healthtech is 20.8 while 3yr average is 21.2.

Has the share price of Influx Healthtech grown faster than its competition?

There is not enough historical data for the companies share price.

Is the promoter bullish about Influx Healthtech?

There is Insufficient data to gauge this.

Are mutual funds buying/selling Influx Healthtech?

There is Insufficient data to gauge this.

INFLUX

Share Price

Financials

Summary

Profit & Loss

Balance sheet

Cashflow

Revenue mix

Product wise

Location wise

Shareholdings

Peers

Forensics

Recent events

News

Corporate Actions

Influx Healthtech Says Completion Of Good Manufacturing Practices Inspection From Tanzania Bureau Of Standards At Facility

Events:

Quarterly Results

More Micro Cap Ideas

Promoter Buying

Capex

Superstar Investor

Popular questions

Business

Financials

Share Price

Shareholdings

What does Influx Healthtech do?

Who are the competitors of Influx Healthtech?

Is Influx Healthtech financially stable compared to its competitors?

Does Influx Healthtech pay decent dividends?

How has Influx Healthtech allocated its funds?

How strong is Influx Healthtech balance sheet?

Is the profitablity of Influx Healthtech improving?

Is the debt of Influx Healthtech increasing or decreasing?

Is Influx Healthtech stock expensive?

Has the share price of Influx Healthtech grown faster than its competition?

Is the promoter bullish about Influx Healthtech?

Are mutual funds buying/selling Influx Healthtech?